Global Hemostasis Analyzers Market 2024 , Forecast To 2033
7 Mar, 2024
The hemostasis analyzers market has experienced strong growth, from $4.84 billion in 2023 to $5.19 billion in 2024, with a CAGR of 7.2%. This growth is fueled by factors like growing prevalence of bleeding disorders and surgical procedures. The market is projected to further grow, reaching $6.89 billion by 2028, driven by factors such as personalized medicine and global health concerns, alongside trends like advances in technology and biomarker-based monitoring.
Global Hemostasis Analyzers Market Key Driver
Increasing awareness regarding blood disorder conditions is driving the hemostasis analyzers market (11). With organizations like the National Hemophilia Foundation raising awareness about blood disorders, there is a growing demand for hemostasis analyzers to improve the diagnosis rate of such conditions, thereby driving market growth.
Get A Free Sample Of The Global Hemostasis Analyzers Market ReportGlobal Hemostasis Analyzers Market Segments
The hemostasis analyzers market covered in this report is segmented –
1) By Product: Clinical Laboratory Analyzers, Point-Of-Care Testing Analyzers, Consumables
2) By Test: APTT Tests, D Dimer Tests, Platelet Function Tests, Fibrinogen Tests, Prothrombin Time Tests, Other Tests
3) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology, Other Technologies
4) By End Use: Hospitals & Clinics, Diagnostic Centers, Research And Development Organisations, Ambulatory Surgical Centers, Other End Uses
By Geography: The countries covered in the hemostasis analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the hemostasis analyzers market in 2023. Western Europe was the second-largest region in the hemostasis analyzers market report. The regions covered in the hemostasis analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Hemostasis Analyzers Industry Players
Thermo Fisher Scientific Inc.; Alere Inc.; Siemens AG; F-Hoffmann La Roche; Nihon Kohden Corporation; Sysmex Corporation; Helena Laboratories; International Technidyne Corporation; Instrumentation Laboratory (A Division of the Werfen Group); Abbott Laboratories; Diagnostica Stago Inc.; Grifols S.A.; Beckman Coulter Inc.; Diamond Diagnostics; Mindray Medical International Limited; Horiba Ltd.; Becton Dickinson and Company; Transasia Bio-Medicals Ltd.; Instrumentation Laboratory; Medtronic Inc.; F. Hoffmann-La Roche AG; Sekisui Diagnostics; Stago; Technoclone; Trinity Biotech plc; Werfen S.A.; Zymo Research; ACON LABS INC.; Accriva Diagnostics
Get The Full Global Hemostasis Analyzers Market Report
Hemostasis Analyzers Market Overview
Hemostasis analyzers are devices that measure clotting mechanisms of hemostasis to detect clotting deficiencies. The natural ability of the body to stop bleeding quickly in order to stop serious blood loss is known as hemostasis.